strategies for medical technology assessment (part 20 of 21)

16
.

Upload: others

Post on 05-May-2022

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Strategies for Medical Technology Assessment (Part 20 of 21)

.

Page 2: Strategies for Medical Technology Assessment (Part 20 of 21)

References

(References for authored papers in apps. E and F arecited

1.

2.

3.

4.

5.

6.

7.

8.

9,

10,

11,

12.

at the end of each paper. )

“Adjuvant Chemotherapy of Breast Cancer, ” Na-tional Institutes of Health Consensus-Develop-ment Conference Statement, N. Eng. J Med.303(14):831, 1980.Almy, T., Sounding Board, “The Role of the Pri-mary Physician in the Health-Care Industry, ” N.Eng. -1. Med. 304(4):225, 1 9 8 1 .Altman, S. H., and Blendon, R. (eds. ), MedicalTechnology: The Culprit Behind Health CareCosts, proceedings of the 1977 Sun Valley Forumon National Health, publication No. (PHS)79-3216 (Washington, D. C.: U.S. GovernmentPrinting Office, 1979).American College of Physicians, Philadelphia,Pa., “ACP News . . . ,“ Nov. 24, 1980.American College of Physicians, Philadelphia,Pa., “Clinical Efficacy Assessment Project: A Pro-posal for Expansion, ” mimeo, n.d.Applied Management Sciences, Inc., and CuadraAssociates, Inc., Catalog of Human Services In-formation Resources Organizations, prepared forthe Office of the Assistant Secretary for Planningand Evaluation, Department of Health and Hu-man Services, contract No. HEW 100-79-0183,June 1980; Project Share Human Services A40no-graph No. 15, October 1980.Arnstein, S. R., “Technology Assessment: Op-portunities and Obstacles,” L5’EE Trans. Syst.Man & Cybern. SMC-7:571, 1977.Arthur Young & Co., and Emergency Care Re-search Institute, A Profile of the MedicaZ TwhnoZ-ogy Industry and Government PoZicies, draft finalreport to the National Center for Health ServicesResearch, Hyattsville, Md., Mar. 31, 1981.Astvad, K., et al., “Mortality From Acute Myo-cardial Infarction Before and After Establishmentof a Coronary Care Unit, ” Br. Med. J. 1:567,1974.Bader, M., letter to the editor, N. Eng. J Med.96(1):46, 1977.Banta, H. D., “Biomedical Research and Technol-ogy Assessment in the Major Medical Clinics, ”presented at the Project HOPE Conference, “TheRole of Major Medical Clinics in Meeting FutureNational Health Needs, ” Millwood, Va., Mar.11-13, 1981.Banta H. D., “The Diffusion of the ComputedTomography (CT) Scanner in the United States, ”Int. J. Health Serv. 10(2):251, 1981.

13.

14.

15.

16.

17.

18.

19.

20.

21.

22.

23.

24.

25.

Banta, H. D., and Behney, C. J., “Medical Tech-nology: Policy and Problems, ” HeaZth Care Mgt.Rev. 5:45, 1980.Banta, H. D., and Behney, C. J., “Policy Formu-lation and Technology Assessment,” prepared forthe Experiment and Social Policy Issue of Healthand Society, Mi]bank Mere. Fund Q. 59(3):445,1981.Banta, H. D., and McNeil, B. J., “Evaluation ofthe CAT Scanner and Other Diagnostic Technol-ogies,” Health Care Mgt. Rev. 3:7, 1978.Banta, H. D., and Sanes, J. R., “Assessing theSocial Impacts of Medical Technologies, ” J.Comm. Health 3(3):245, 1978.Banta, H. D., and Thacker, S. B., “Assessing theCosts and Benefits of Electronic Fetal Monitor-ing,” Obstet. & Gyn. Survey 34:627, 1979.Banta, H. D., et al., “Implications of the 1976Medical Devices Legislation,” Man & Medicine3:131, 1978.Banta, H. D., et al., Toward Rational Technol-ogy in Medicine (New York: Springer PublishingCo., 1981).Barsamian, E. M., “The Rise and Fall of InternalMammary Artery Ligation in the Treatment ofAngina Pectoris and the Lessons Learned, ” inCosts, Risks, and Benefits of Surgery, J. P.Bunker, et al. (eds. ) (New York: Oxford Univer-sity Press, 1977).Bauer, R. A., and Wortzel, L. H., “DoctorsChoice: The Physician and His Sources of Infor-mation About Drugs, ” J. Mktg. Research 3:4o,1966.Beebe, G. W., “Record Linkage and Needed Im-provements in Existing Data Resources, ” pre-sented at the Banbury Conference on Occupa-tional Cancer, Cold Spring Harbor Laboratory,Cold Spring Harbor, N. Y., Mar. 29-Apr. 2, 1981,Beebe, G. W., “Record Linkage Systems—Can-ada vs. the United States, ” Am. J. Public Health70(12):1246, 1980.Beebe, G. W., “Some Aspects of Record Linkagein Epidemiologic Research in the U.S., ” paperpresented at the Workshop on Computerized Rec-ord Linkage in Cancer Epidemiology, Ottawa,Canada, Aug. 8-10, 1979.Behney, C. J., “The Turning Outward of the Na-tional Institutes of Health,” presented at the 13thAnnual Meeting of the Association for the Ad-vancement of Medical Instrumentation, Washing-ton, D. C., Apr. 1, 1978.

205

Page 3: Strategies for Medical Technology Assessment (Part 20 of 21)

206 ● Strategies for Medical Technology Assessment

26.

27.

28.

29.

30.

31.

32.

33.

34,

35.

36.

374

38,

39,

Berk, A. A., and Chalmers, T. C., “Cost and Ef-ficacy of the Substitution of Ambulatory for In-patient Care,” N. Ehg. J. Med. 304:393, 1981.Bessant, J., “Innovation Research: To What Ex-tent Can It Provide Answers?” Planned hmova-tion 2(2):52, 1979.Bice, T., et al., Executive Summary of the Con-fidence on Capital Fhancing for Health Facilities,sponsored by the Health Resources Administra-tion and the University of Pittsburgh, Pittsburgh,Pa., Nov. 19-21, 1976,Bilitch, M., Project Director, University of South-ern California, Los Angeles, California, l?egist~for Implanted Artificial Cardiac Pacemakers: 66Month Report, contract No. 223-79-5060, sub-mitted to the Food and Drug Administration,Rockville, Md., Mar. 28, 1980.Birch & Davis Associates, Inc., IDD EvaluationProject Hospital FieZdManual, contract No. 500-80-0047, submitted to the Health Care FinancingAdministration, Washington, D. C., 1980.Birch & Davis Associates, Inc., IDD GranteeProject Synopsis, contract No. 500-80-0047, sub-mitted to the Health Care Financing Administra-tion, Washington, D. C., Dec. 17, 1980.Birch & Davis Associates, Inc., Integrated DataBmonstration Evaluation Study, contract No.500-80-0047, submitted to the Health Care Fi-nancing Administration, Washington, D. C., Oct.8, 1980.The Blue Sheet, “Coordinated Health Informa-tion System Feasibility ‘Yet To Be Demonstrated, ’HHS’ Brandt Tells Hill; Cost, Quality, Confiden-tiality Are Seen As Problems, ” 24:9, June 10,1981.Bonchek, L. I., “Are Randomized Trials Appro-priate for Evaluating New Operations?” N. Eng.J. Med. 301:44, 1979.Breslow, L., University of California, Los Ange-les, personal communication, 1981.Bryant, F. B., and Wortman, P. M., “SecondaryAnalysis: The Case for Data Archives,” Am. Psy-chol. 33:381, 1978.Bumpus, F. M., “The Role of Major Medical Clin-ics in Research, ” presented at the Project HOPEconference, “The Role of Major Medical Clinicsin Meeting Future National Health Needs, ” Mill-wood, Va., Mar. 11-1,3, 1981.Bunker, J. P., Stanford, Calif., personal commu-nication, June 16, 1981.Bunker, J. P., et al., “Assessment of MedicalTechnology Strategies: Coverage and Reimburse-ment Options for Experimental Medical and Sur-gical Procedures, ” prepared for the Office of

40.

41.

42.

43.

44,

45.

46

47

48.

49.

50.

51

52.

53.

Technology Assessment, U.S. Congress, Wash-ington, D. C., September 1981.Bunker, J. P., et al., “Surgical Innovation and ItsEvaluation,” %ience 200:937, 1978.Bunning, R. L. “The Delphi Technique: A Projec-tion Tool for Serious Inquiry,” in The 1979 h-nual Himdbook for Group Facilitators, J. E. Jones,J. W, Pfeiffer (eds. ) (La Jolla, Calif.: UniversityAssociates, 1979).Byar, D. P., et al., “Randomized Clinical Trials:Perspectives on Some Recent Ideas, ” N. Eng. J.Med. 295(2):74, 1976.Campbell, D. T., and Boruch, R. F., “Making theCase for Randomized Assignment to Treatmentsby Considering the Alternatives: Six Ways inWhich Quasi-Experimental Evaluations in Com-pensatory Education Tend To Underestimate Ef-fects,” in Evaluation and &periment: Some Giti-cal Issues in Assessing Social Programs, C. A.Bennett and A. A. Lumsdaine (eds. ) (New York:Academic Press, 1975).Campbell, D. T., and Erlebacher, A., “How Re-gression Artifacts in Quasi-Experimental Evalua-tions Can Mistakenly Make Compensatory Edu-cation Look Harmful, ” in Compensatory Educa-tion: A NationaZ Debate, J. Helmuth (cd.), vol.111 of The ll”sadvantaged Child (New York: Brun-ner/Mazel, 1970).Campbell, D. T., and Stanley, J. C., lkperimen-tal and Quasi-Experimental Bsi@s for Research(Chicago: Rand-McNally, 1966).CapIan, A. L., Hastings Center, Hastings-on-the-Hudson, N. Y., personal communication, Novem-ber 1981.Caplan, A. L., “Ethical Engineers Need Not Ap-ply: The State of Applied Ethics Today, ” Sci.Technol Human VaZ. 6(33):24, 1980.Caplan, A. L., “Kidneys, Ethics, and Politics:Policy Lessons of the ESRD Experience,” J. HeaZthPolit. Policy Law 6:488, 1981.Caplow, T., Principles of Organization (NewYork: Harcourt, Brace & World, 1964).Center for the Analysis of Health Practices, Har-vard School of Public Health, “Impact on HealthCosts of NCHCT Recommendations To With-hold Reimbursement for New Medical Proce-dures,” unpublished, February 1981.Chalmers, T. C., “The Clinical Trial, ” MilbankMere. Fund Q. 59(3):324, 1981.Chalmers, T. C., “Randomization Coronary Ar-tery Surgery,” Ann. Thorac. Surg. 14:323, 1972.Chalmers, T. C., et al., “Controlled Studies inClinical Cancer Research, ” N. Eng. J. Med.287:75, 1972.

Page 4: Strategies for Medical Technology Assessment (Part 20 of 21)

References . 207

54.

55.

56.

57.

58.

59.

60.

61,

62.

63.

64.

65,

66.

67.

68.

69.

Chalmers, T. C., et al., “A Method for Assess-ing the Quality of a Randomized Clinical Trial, ”Contr. C/in. Triak 2:31, 1 9 8 1 .Charles River Associates, Inc. “The Effects ofPatent-Term Restoration on the PharmaceuticalIndustry,” prepared for the Office of TechnologyAssessment, U. S. Congress, Washington, D. C.,May 4, 1981.Charters, A. C., and Bailey, R. N., “ExperienceWith a Simplified Trauma Registry: Profile ofTrauma at a University Hospital, ” J Trauma19:13, 1979.Childress, J. F., Priorities in Biomedical Ethics(Philadelphia: Westminster Press, 1981).Christenson, D. B., and Wertheimer, A. I.,“Source of Information and Influence on NewDrug Prescribing Among Physicians in anHMO,” Soc. Sci. Med. 13A:313, 1979.Clarke, R. V. G., and Cornish, D. B., The Con-trolled Trial Institutional Research (London:Home Office Research Studies, 1972).Cochrane, A. L., Effectiveness and Efficiency:Random Reflections on Health Services (London:Burgess, 1972).Cole, P., “The Evolving Case-Control Study,” JCYwon. Dis. 32:15, 1979.Coleman, J. S., et al., MedikaZ Innovation: A Dif-fusion Study (Indianapolis: Bobbs-Merrill, 1966).Committee on the Life Sciences and Social Policy,Assessing Biomedical Technologies: An InquiryInto the Nature of the Process (Washington,D. C.: National Academy of Sciences, 1975).Comroe, J. H., Jr., and Dripps, R. D., The TopTen Clinical Advances in Cardiovascular-Pulmo-nary Medicine and Surgery, 1945-1975, vol. I,Final Report, DHEW Publication No. (NIH) 78-1521, Jan. 31, 1977.Congressional Research Service, Library of Con-gress, Competitive Problems in the Drug Indus-try: Fixed-Dose Combination Antibiotic Drugs,prepared for the Select Committee on Small Busi-ness, U.S. Senate, May 1, 1979 (Washington,D. C.: U.S. Government Printing Office, 1979).Conner, R. F., “Selecting a Control Group: AnAnalysis of the Randomization Process in TwelveSocial Reform Programs, ” Eva]. Q. 1:195, 1977.“Consensus Conference: Diagnosis and Treat-ment of Reye’s Syndrome, ” J. A.M.A. 246:2441,1981.Cook, T. D., and Campbell, D. T., Quasi-13qeri-mentation: Zkign and Analysis of Research inField Settings (Chicago: Rand McNally, 1979).Cook, T. D., and Leviton, L. C., “Reviewing theLiterature: A Comparison of Traditional Methods

70,

71,

72<

73,

74$

75.

76,

77,

78,

With Meta-Analysis, ” J. Personality 48(4):449,1980.Cook, T. D., and Reichardt, C. S., “Guidelines:Statistical Analysis of Nonequivalent ControlGroup Designs: A Guide to Some Current Litera-ture,” Evaluation 3(1-2):136, 1976.Cordray, D. S., and Lipsey, M. W., “Usir-tg Pat-terns of Evidence in Social Program Evaluation:An Overview and Illustration, ” presented at themeeting of the Evaluation Research Society, Min-neapolis, 1979.Coronary Drug Project Research Group, “Influ-ence of Adherence to Treatment and Response ofCholesterol on Mortality in the Coronary DrugProject,” N. Eng. J. Med. 303:18, 1980.Cowley, M. J., and Block, P. C., “PercutaneousTransluminal Coronary Angioplasty, ” M o d .Concepts Cardiovasc. Dis. 50(5):2, 1981.Crawford, S., “Health Science Libraries in theUnited States, 1969 to 1979, ’’J. A. A4. A. 245:237,1981.Cromwell, J., et al., Incentives and DecisionsUnderlying Hospitals’ Adoption and Utilizationof Major CapitaZ Equipment (Cambridge, Mass,:Abt Associates, 1975).Cronbach, L. J., and Furby, L., “How Should WeMeasure ‘Change’—Or Should We?” Psycho].Bull. 74:68, 1970.Dalkey, N. C., The Delphi Method: An Experi-mental Study of Group Opinion (Santa Monica,Calif.: Rand Corp., 1969).Dalkey, N. C., and Helmer, O., “An Experimen-tal Application of the Delphi Method t: the Useof Experts,” A@. Sci. 9(3):458, 1963.

79. D’Arbeloff, D. V., Chairman and Chief Executive

80,

81

Officer, Millipore Corp., statement at Workshopon Innovation and Reimbursement for the StudyStrategies for Medical Technology Assessment,Office of Technology Assessment, U.S. Congress,Washington, D. C,, May 13, 1981.David, G,r Commission on Professional and Hos-pital Activities, Ann Arbor, Mich., personal com-munication, May 21, 1981.Deckert, T., et al., “Prognosis of Diabetics WithDiabetes Onset Before tie Age of Thirty-One,’i

Diabetologia 14:363, 1978.82. Delbecq, A., et al., Group Techniques for Pro-

gram Planning (Glenview, Ill.: Scottf Foresman& co., 1975).

83. Department of Commerce, National TechnicalInformation Service, Biomedical TechnoZogyana’Human Factors Engineering, Aug. 5, 1980,PB80-909532 (Springfield, Va.: NTIS, 1981).

84. Department of Commerce, National Technical

Page 5: Strategies for Medical Technology Assessment (Part 20 of 21)

208 Strategies for Medical Technology Assessment

85,

86.

87.

88.

89.

90.

91.

92,

93.

94.

Information Service, General Catalog of I.nfor-rnation %-vices, No. 7a (Springfield, Va.: NTIS,1981).Department of Commerce, National TechnicalInformation Service, Health PZanning artd HealthServices Research, May 19, 1981, PB81-904420 (Springfield, Va.: NTIS, 1981).Department of Commerce, National TechnicalInformation Service, JVTIS Information Servicesfor Productivity, Technology, and Innovation,information packet (Springfield, Va.: NTIS,1981).Department of Health, Education, and Welfare,National Center for Health Services Research,Medical Technology, publication No. (PHS)79-3254 (Washington, D. C.: U.S. GovernmentPrinting Office, 1979).Department of Health, Education, and Welfare,National Commission for the Protection of Hu-man Subjects of Biomedical and Behavioral Re-search, The Belmont Report, DHEW publicationNo. (OS) 78-0012, 1978.Department of Health, Education, and Welfare,National Commission for the Protection of Hu-man Subjects of Biomedical and Behavioral Re-search, The S’cial Study: Implications of Ad-vances in Biomedical and Behavioral Research,1978.Department of Health, Education, and Welfare,Office of the Assistant Secretary for Health/Pub-lic Health Service, “NCHCT Fact Sheet,” n.d.Department of Health, Education, and Welfare,Office of the Assistant Secretary for Plaming andEvaluation and the Office of the Assistant Secre-tary for Health, Health Tmhno]ogy Managementat the Department of Health, Education, andWelfare, Final Phase I Report for the Secretary,1977.Department of Health, Education, and Welfare,Public Health Service, Health Resources Adminis-tration, Bureau of Health Planning, The NationalHealth Planning Information Center, DHEWpublication No. (HRA) 79-14007, October 1978.Department of Health, Education, and Welfare,Public Health Service, National Center for HealthServices Research, “Clinical Databanks—An Epi-demiological Approach to Technology Assess-ment and Consensus Development, ” presented atthe XII International Conference on Medical andBiological Engineering, Jerusalem, Israel, Aug.19-24, 1979.Department of Health, Education, and Welfare,Public Health Service, National Center for HealthServices Research, Computer Applications in

95.

96.

97,

98.

99.

100.

101.

102.

103.

104(

1054

Health Care, DHEW publication No. (PHS) 79-3251, June 1979.Department of Health, Education, and Welfare,Public Health Service, National Institutes ofHealth, “Consensus Development ConferenceStatement,” N. fig. J. Med. 304:680, 1981.Department of Health, Education, and Welfare,Public Health Service, National Institutes ofHealth, Consensus Development ConferenceSummaries, vol. 1, 1977-1978.Department of Health, Education, and Welfare,Public Health Service, National Institutes ofHealth, Consensus Development ConferenceSummaries, vol. 2, 1979.Department of Health, Education, and Welfare,Public Health Service, National Institutes ofHealth, Consensus IXvelopment ConferenceSummaries, vol. 3, 1980.Department of Health, Education, and Welfare,Public Health Service, National Institutes ofHealth, NIH Inventory of Clinical Trials: FiscalYear 1975, vols. I and II, 1977.Department of Health, Education, and Welfare,Public Health Service, National Institutes ofHealth, “Program Description and Data Format:Cancer Surveillance Epidemiology and End Re-sults (SEER) Reporting Program, ” unpublished,April 1976,Department of Health, Education, and Welfare,Public Health Service, National Institutes ofHealth, “The Responsibilities of NIH at theHealth Research/Health Care Interface, ” draft,Feb. 14, 1978.Department of Health and Human Services,Health Care Financing Administration, “HealthCare Information System of the 80’s: HCFA’S Per-spective and Initiatives, ” discussion paper, May14, 1980.Department of Health and Human Services,Health Care Financing Administration, “Operat-ing Guidelines for Determining Medical Neces-sity of Medicare Items and Services, ” draft, Feb.2, 1971.Department of Health and Human Services,Health Care Financing Administration, Office ofResearch, Demonstrations, and Statistics, Grantsfor Research and LXmonstrations, Fiscal Year1981, HCFA Publication No. 03074, December1980.Department of Health and Human Services,Health Care Financing Administration, Office ofResearch, Demonstrations, and Statistics, “AGuide to ORDS Publications, ” mimeo, August1980.

Page 6: Strategies for Medical Technology Assessment (Part 20 of 21)

References ● 209

106.

107.

108.

109.

110.

111

112.

113.

114.

115.

Department of Health and Human Services,Health Care Financing Administration, Office ofResearch, Demonstrations, and Statistics, “ORDSResearch Publications, ” mimeo, n.d.Department of Health and Human Services,Health Care Financing Administration, Office ofResearch, Demonstrations, and Statistics, “Re-search Publications Program, ” mimeo, n.d.Department of Health and Human Services, Of-fice of the Assistant Secretary for Health/PublicHealth Service, Maternal Serum Alpha-Fetopro-tein: Issues in the Prenatal Screening and Diagno-sis of Neural Tube Bfects, National Center forHealth Care Technology Conference Proceedings,Washington, D. C., July 28-30, 1980.Department of Health and Human Services,Office of the Assistant Secretary for Health/Pub-lic Health Service, National Center for HealthCare Technology, “Hemodialysis for Treatmentof Schizophrenia, ” memorandum to the HealthCare Financing Administration, Sept. 18, 1980.Department of Health and Human Services,Office of Assistant Secretary for Health/PublicHealth Service, National Center for Health CareTechnology, “Procedures, Priorities and Policyfor Assessment of Health Care Technology,”Sept. 1, 1980.Department of Health and Human Services,Office of the Assistant Secretary for Health/Pub-lic Health Service, National Center for HealthCare Technology, “The Process for AssessingTechnologies, ” Jan. 21, 1981.Department of Health and Human Services,Office of the Assistant Secretary for Health/Pub-lic Health Service, National Center for HealthCare Technology, Report to the Congress, 1980.Department of Health and Human Services,Office of the Assistant Secretary for Health/Pub-lic Health Service, National Center for HealthServices Research, Program Description, Jan. 9,1981.Department of Health and Human Services,Office of the Assistant Secretary for Health/Pub-lic Health Service, National Center for HealthStatistics, Data Systems of the National Centerfor Health Statistics, DHEW publication No.(PHS) 80-1247, 1980.Department of Health and Human Services,Office of the Assistant Secretary for Health/Pub-1ic Health Service, National Center for HealthStatistics, Directions for the ‘80s: Final Report ofthe Panel To Evaluate the Cooperative HealthStatistics System, DHHS publication No. (PHS)80-1204, August 1980.

116.

117.

118.

119.

120.

121.

122.

123.

124.

125.

Department of Health and Human Services,Office of the Assistant Secretary for Health/Pub-lic Health Service, National Center for HealthStatistics, Environmental Health: A PZan for Col-lecting and Coordinating Statistical and Epide-miologic Data, DHHS publication No. (PHS) 80-1248, 1980.Department of Health and Human Services,Office of the Assistant Secretary for Health/Pub-lic Health Service, National Center for HealthStatistics, HeaZth; United States, 1980, DHHSpublication No. (PHS) 81-1232, October 1980.Department of Health and Human Services,Office of the Assistant Secretary for Health/Pub-lic Health Service, National Council for HealthCare Technology, Annual Report, Fiscal Year1979, n.d.Department of Health and Human Services,Office of the Assistant Secretary for Health/Pub-lic Health Service, National Council for HealthCare Technology, minutes of meeting, Washing-ton, D. C., Aug. 13, 1981.Department of Health and Human Services,Office of the Assistant Secretary for Health/Pub-lic Health Service, Technology Coordinating

Committee, minutes of meeting, Apr. 27, 1981.Department of Health and Human Services,Office of the Assistant Secretary for Planning andEvaluation, “Project Share: A National Clearing-house for Improving the Management of HumanServices,” DHHS publication No. 0$76-221,1981.Department of Health and Human Services, Pub-lic Health Service, Food and Drug Administra-tion, Office of Planning and Evaluation, Econom-ics Staff, “Baseline Data on Medical Device Indus-tries in the Census of Manufacturers,” OPE study53, 1980.Department of Health and Human Services, Pub-lic Health Service, Health Resources Administra-tion, Bureau of Health Planning, “The NationalHealth Planning Information Center: Its Concep-tion, Development, and Organization, ” mimeo,n.d.Department of Health and Human Services, Pub-lic Health Service, Health Resources Administra-tion, Bureau of Health Planning, “services Pro-vided by the National Health Planning Informa-tion Center,” mimeo, June 1980.Department of Health and Human Services, Pub-lic Health Service, National Institutes of Health,NIHPublic Advisory Groups: Authority, Struc-ture, Functions, Members, publication No. (NIH)79-lI, Jan. 1, 1979.

Page 7: Strategies for Medical Technology Assessment (Part 20 of 21)

210 ● Strategies for Medical Technology Assessment

126<

127.

128.

129

130.

131

132

133

134.

135.

136.

137

138

Department of Health and Human Services, Pub-lic Health Service, National Institutes of Health,National Heart, Lung, and Blood Institute, Officeof Information, “Coronary Artery SurgeryStudy,” unpublished, 1981.Department of Health and Human Services, Pub-lic Health Service, National Institutes of Health,National Heart, Lung and Blood Institute, Officeof Information, “The Framingham Heart Study, ”unpublished, 1981.Department of Health and Human Services, Pub-lic Health Service, National Institutes of Health,National Heart, Lung, and Blood Institute, Officeof Information, “Multiple Risk Factor Inter-vention Trial for the Prevention of CoronaryHeart Disease, ” n.d.Department of Health and Human Services, Pub-lic Health Service, National Institutes of Health,National Library of Medicine, Lister Hill NationalCenter for Biomedical Communications, “TheHepatitis Knowledge Base,” Arm. ht. Nfed.93(l) (Part 2):165, 1980.Dowling, H. F., cited in Competitive Problemsin the Drug Industry: FhedDose CombinationAntibiotic Drugs, prepared by the CongressionalResearch Service, Library of Congress, for theSelect Committee on Small Business, U.S. Senate,May 1, 1979 (Washington, D. C.: U.S. Govern-ment Printing Office, 1979).DuMouchel, W. H., and Harris, J. E., “BayesMethods for Combining Cancer Experiments inMan and Other Species,”J. Amer. Statist. Assoc.,in press, 1982.Duncan, K. A., Palo Alto, Calif. “The TrendToward a National Health Information Systemin the United States, ” unpublished paper, n.d.“Editorial: New Insulin-Delivery Systems forDiabetics,” Lancet 1:1275, 1979.Einhorn, H. J., and Hogarth, R. M., “Confidencein Judgment: Persistence in the Illusion of Validi-ty,” Psycho]. Rev. 85:395, 1978.Enzer, S., et al., Some Societal Changes by 1985and Their Impacts on Time/Money Bu~et (Mid-dletown, Corm.: Institute for the Future, 1971).European Coronary Surgery Study Group,“Coronary-Artery Bypass Surgery in Stable An-gina Pectoris: Survival at Two Years, ” Lancet1:889, 1979.Eysenck, H, F., “An Exercise in Mega-Silliness, ”Am. Psychol. 33:517, 1978.Federal Coordinating Committee on Science, En-gineering and Technology, Ad Hoc Committeeon Scientific and Technical Information, “Reportof the Working Group on Private Sector/Govem-

139.

140,

141,

142.

143.

144.

145.

146,

147,

148.

149.

150.

151.

152(

153<

ment Relations for Scientific and Technical Infor-mation, ” mimeo obtained from the National Sci-ence Foundation, Washington, D. C., June 1980.Feer, H., et al,, Compr. Psychiatry 1:338, 1960,cited in S. C. Schulz, et al., “Dialysis in Schizo-phrenia: A Double-Blind Evaluation, ” Science211:1066, 1981.Fein, R., “On Measuring Economic Benefits ofHealth Programs, “ in Ethics and Health Policy,R. M. Veatch and R. Branson (eds.) (Cambridge,Mass.: Ballinger, 1976).Feinstein, A. P., “A Survey of the Statistical Pro-cedures in General Medical Journals,” C’lin. Phar-macol. Therapeut. 15:97, 1975.Feldstein, M., and Taylor, A., The Rapid Riseof Hospital Costs (Washington, D. C.: President’sCouncil on Wage and Price Stability, 1977).Fineberg, H. V., “Gastric Freezing—A Study ofDiffusion of Medical Innovation, ” in MedicalTechnology and the Health Care System (Wash-ington, D. C.: National Academy of Sciences,1979).Fineberg, H. V., and Hiatt, H. H., “Evaluationof Medical Practices: The Case for TechnologyAssessment,” IV. fig. J. Med. 301:1086, 1970.Fineberg, H. V., et al., “Acquisition and Applica-tion of New Medical Knowledge by Anesthesiolo-gists: Three Recent Examples,” Anesthesiology48:430, 1978.Fishbein, H. A., State of Rhode Island Depart-ment of Health, Providence, R. I., personal com-munication, May 7, 1981.Fisher, B., “Breast-Cancer Management: Alter-natives to Radical Mastectomy, ” IV. fig. J. Med.301:326, 1979.Fletcher, R. H., and Fletcher, S. W., “ClinicalResearch in General Medical Journals, ” Al. Eng.J Med. 301:180, 1979.Frank, J. D., Persuasion and Healing (Baltimore:Johns Hopkins University Press, 1973).Frankina, W. K., Ethics (Englewood Cliffs, N. J.:Prentice-Hall, 1973).Freeman, C., The Role of Small Ftims in Innova-tion in the United Kingdom Since 194s, reportto the Bolton Committee of Inquiry on SmallFirms, research report No. 6 (London: Her Maj-esty’s Stationery Office, 1971).Freeman, G,, Blue Cross/Blue Shield Association,Chicago, 111., personal communication, May1981.Freiman, J. A., et al., “The Importance of Beta,the Type II Error and Sample Size in the Designand Interpretation of the Randomized ControlTrial,” N. fig. J. Med. 299:690, 1978.

Page 8: Strategies for Medical Technology Assessment (Part 20 of 21)

References 2 1 1——

154.

155.

156.

157.

158.

159<

160

161.

162.

163.

164.

165.

166.

167.

General Accounting Office, U.S. Congress, FDADrug Approval: A Lengthy Process That Delaysthe Availability of Important New Drugs, reportby the Comptroller General of the U.S. to theSubcommittee on Science, Research, and Tech-nology, House Committee on Science and Tech-nology, U.S. Congress, May 28, 1980.General Accounting Office, U.S. Congress, 0PA4Should Promote Medical Necessity Programs forFederal Employees’ Health Insurance (Washing-ton, D. C.: U.S. Government Printing Office, July29, 1980).Gerstenfeld, A., “A Study of Successful Projects,Unsuccessful Projects, and Projects in Process inWest Germany, ” WEE Trans. Eng. Mgt.EM-23(3):116, 1976.Gifford, R. H., and Feinstein, A. R., “A Critiqueof Methodology in Studies of AnticoagulantTherapy for Acute Myocardial Infarction, ” N.Eng. J. Med. 280:351, 1969.Gilbert, J. P., et al., “Assessing Social Innova-tions: An Empirical Base for Policy, in Evalua-tion and fiperiment: Some Critical Issues in As-sessing Social Programs, C. A. Bennett andA. A. Lumsdaine (eds. ) (New York: AcademicPress, 1975).Gilbert, J. P., et al., “Progress in Surgery andAnesthesia: Benefits and Risks of InnovativeTherapy, “ in Costs, Risks, and Benefits of Sur-gery, J. P. Bunker, et al. (eds. ) (New York: OX-ford University Press, 1977).Gilbert, J. P., et al., “Statistics and Ethics in Sur-gery and Anesthesia,” science 198:684, 1977.Gillings, D., et al., “Analysis of Interrupted TimeSeries Mortality Trends: An Example To EvaluateRegionalized Perinatal Care, ” Am. -1 PublicHealth 71:38, 1981.Ginsburg, P., “Resource Allocation in the Hospi-tal Industry: The Role of Capital Financing,” Soc.%?C. Bull. 35:20, 1972.Glaser, E. M., “Using Behavioral Science Strat-egies for Defining the State of the Art, ” -1 Ap-plied Behav. Sci. 16:79, 1980.Glass, G. V., “Integrating Findings: The Meta-Analysis of Research, “ in Review of Research inEducation, vol. 5, L. S. Shulman (cd.) (Itasca, Ill.:Peacock, 1977).Glass, G. V., “Primary Secondary, and Meta-Analysis of Research, ” Educ. Res. 5:3, 1976.G1ass, G. V., and Smith, M. L., “Meta-Analysisof Research on Class Size and Achievement, ”Educ. Evaluat. Policy Analysis 1:2, 1979.Glass, G. V., et al., The Design and Analysis of

168.

169.

170.

171.

172,

173.

174.

175,

176.

177.

178.

179,

180.

181.

182.

Time-Series Experiments (Boulder, Colo.: Colo-rado Associated University Press, 1975).Goldschmidt, P . , Veterans Administration,Washington, D. C., personal communication,January 1982.Gordis, L., et al., “Pitfalls in Evaluating the Im-pact of Coronary Care Units on Mortality FromMyocardial Infarctions,” Johns Hopkins Med. J.141:287, 1977.Gore, S. M., “Assessing Clinical Trials—FirstSteps,” Br. Med. J. 282:1605, 1981.Gore, S. M., “Assessing Clinical Trials—TrialSize,” Br. Med. J. 282:1687, 1981.Gore, S. M., et al., “Misuse of StatisticalMethods: Critical Assessment of Articles in BMJFrom January to March 1976,” Br. Med. J. 1:85,1977.Gottman, J. M., “N-of-One and N-of-Two Re-search in Psychotherapy, ” Psycho]. Bull. 80:93,1973.Grabowski, H. G., et al., “The Effects of Regula-tory Policy on the Incentives To Innovate: AnInternational Comparative Analysis, ” in Impactof Public Policy on Drug Innovation and Pric-ing, S. A. Mitchell and E. A. Links (eds. )(Washington, D. C.: The American University,1976).Grace, N. D., et al., “The Present Status ofShunts for Protal Hypertension Incirrhosis, ”Gastroent. 50:684, 1966.The Gray Sheet “Restricted Device Case-by-CaseAlternative Unanimously Urged by Associa-tions,” 7(4): I&W8, Jan. 26, 1981.The Gray Sheet, “Mandatory Experience Report-ing Proposal Unanimously Criticized by Manu-facturers,” 7(6), Feb. 9, 1981.Greer, A. L., “Advances in the Study of Diffu-sion of Innovation in Health Care Organiza-tions,” Milbank Mere. Fund Q. 55:5o5, 1977.Hale, W. E., et al., “Drug Use in a GeriatricPopulation,”J. Am. Geriat. SoC. 23(S) :374, 1979.Hammermeister, K. E., et al., “Effect of Aorto-coronary Saphenous Vein Bypass Grafting onDeath and Sudden Deatl-i, ” Am. J. CardioJ.39:925, 1977.Hammermeister, K. E., et al., “Evidence From aNonrandomized Study That Coronary SurgeryProlongs Survival in Patients With Two-VesselCoronary Disease, ” Circulation 59:430, 1979.Harris, J. E., IWacro-fiperiments Versus Micro-Ekperiments for Health Policy (No. 286A) (Cam-bridge, Mass.: Massachusetts Institute of Tech-nology Press, 1981).

Page 9: Strategies for Medical Technology Assessment (Part 20 of 21)

212 ● Strategies for Medical Technology Assessment

183

184,

185,

186.

187.

188.

189.

190.

191.

192.

193.

194.

195.

196.

197.

198.

199.

Hayes, R. H., and Abernathy, W. J., “Manag-ing Our Way to Economic Decline, ” HarvardBus. Rev. 58(4):68, 1980.Hecht, A., “Drug Effects on the Eyes,” FDA Con-sumer, November 1978, p. 14.Hecht, A., “Tracking the Skin’s Reactions toDrugs,” FDA Consumer, April 1981, p. 5.Hedges, L. V., and Olkin, I., “Vote-CountingMethods in Research Synthesis,” Psychol. Bull.88:359, 1980.Hill, A. B., Controlled CZinicaZ Trials (Spring-field, Ill.: Charles C, Thomas, 1960).Hill, J. D., et al., “A Randomised Trial of Home-Versus-Hospital Management for Patients WithSuspected Myocardial Infarction, ” Lancet 1:837,1978.Hobbins, J. C., et al., “The Fetal Monitoring De-bate,” Pediatrics 63:942, 1979.Hoehler, F, K., et al., “Spinal Manipulation forLow Back Pain,” J. A.M.A. 245:1835, 1981.Horwitz, R. I., and Feinstein, A. R., “AlternativeAnalytic Methods for Case-Control Studies of Es-trogens and Endometrial Cancer, ” N. Eng. JMed. 299(20):1089, 16, 1978.)Horwitz, R. I., et al., “Necropsy Diagnosis of En-dometrial Cancer and Detection—Bias in Case/Control Studies,” Lancet 2:66, 1981.Hubbard, W. N., Jr., President, Upjohn Co., tes-timony at the hearings on The Depo-provera D-bate before the Select Committee on Population,U.S. House of Representatives, Aug. 8, 1978(Washington, D. C.: U.S. Government Printingoffice, 1978).Hulka, B. S., et al., “Physician Management inPrimary Care,” Am. J. Public Health 66:1173,1966.Hummel-Rossi, B., and Weinberg, S. L., “Prac-tical Guidelines in Applying Current Theories tothe Measurement of Change,” JSAS Catalog ofSHected Documents in Psychology (Ms. No. 916)5:226, 1975.Hutchinson, G. B., and Rothman, K. J., “Cor-recting a Bias?” N. Eng. J. Med. 299:1129, 1978.Institute of Medicine, National Academy ofSciences, Conference Summary: Evaluating Med-ical Technologies in Clinical Use (Washington,D. C.: NAS, 1981).Institute of Medicine, National Academy of Sci-ences, Reliability of Hospital Discharge Abstracts(Washington, D. C.: NAS, 1980).Institute of Medicine, National Academy of Sci-ences, Reliability of Medicare Hospital Discharge

200,

201.

202.

203.

204.

205.

206

207,

208.

209.

210.

211.

212.

213.

214.

215.

216.

Records (Washington, D. C.: NAS, November1977).Jick, H., et al., “Vaginal Spermicides and Con-genital Disorders, ’’J.A. M.A. 245(13):1329, 1981.]oint Commission on Prescription Drug Use, Inc.,Report of the Joint Commission on PrescriptionDrug Use: Appendix IL Minutes of Meetingsr

minutes of June 20-21, 1978 (Rockville, Md.: Jan.23, 1980).Jones, R, R., et al., “Time-Series Analysis inOperant Research, ” J AppZied Behav. Analysis10:151, 1977.Jones, S. E., “Adjuvant Chemotherapy for BreastCancerJ” J. A.M.A. 245:1527, 1981.Jensen, A. R,, “The Totally Implantable ArtificialHeart,” Hast. Cent. Rpt. 3(5):1, 1973.Jensen, A. R., and Butler, L. H., “Public Ethicsand Policy Making, ” Hast. Cent. Z?pt. 5(4):19,1975.Joreskog, K. G., “A General Approach to Con-firmatory Maximum Likelihood Factor Analysis,”Psychometrika 34:183, 1969.Kaiser Foundation Health Plan, Oakland, Calif.,“Kaiser-Permanente Medical Care Program An-nual Report 1980, ” n.d.Katz, E., et al., “Traditions of Research on theDiffusion of Innovation,” Amer. Sociol. 28:237,1963.Kennedy, R. H., et al., “Necrologic ComputedTomography in a Defined Population Group,”Radiology 106:1, 1979.Kennedy, R. H., et al., “Trends in Cardiac Sur-gery: Five-Year Study of a Defined Population, ”Thoracic Cardiovasc. Surg. 80(5):702, 1980.Kennedy, R. H., et al., “Use of the Cardiac-Cath-eterization Laboratory in a Defined Population, ”N. Eng. J, Med. 303:1273, 1980.Kimberly, J. R., “Hospital Adoption of Innova-tion: The Role of Integration Into External Infor-mation Environments, ” J. Health Soc. Behav.19:361, 1978.Kimberly, J. R., “Managerial Innovation, ” inHandbook of Organizational Design, P. C.Nystrom and W. H. Starbuck (eds. ) (New York:Oxford University Press, 1981).Kohrrnan, A., Washington, D. C., personal com-munication, 1981.Kolata, G. B., “Dilemma in Cancer Treatment, ”%ience 209:792, 1980.Krol, R, A., “A Meta-Analysis of ComparativeResearch on the Effects of Desegregation on Aca-demic Achievement, ” unpublished doctoral dis-

Page 10: Strategies for Medical Technology Assessment (Part 20 of 21)

References ● 213

217,

218,

219

220.

221.

222.

223.

224,

225.

226.

227,

228.

229.

230.

231,

232.

sertation, University of Michigan, Ann Arbor,Mich., 1979.Kuhn, T. S., The Structure of Scientific Revolu-tions (Chicago: University of Chicago Press,1970).Kunitz, S., et al., “Pilot Data Bank Networks forNeurological Disorders, ” in Third Annual Pro-ceedings of the Symposium of Medical Care(Long Beach, Calif.: IEEE Computer Society,1979).Langrish, J., et al., Wealth From Knowle~e(London: Macmillan, 1972).Lave, L. B., and Seskin, E. P., “Epidemiology,Causality and Public Policy, ” Am. Sci. 67:178,1979.Lebacqz, K., “Bioethics: Some Challenges Froma Libertarian Perspective, ” presented at the Con-ference on Faith, Science, and the Future, Cam-bridge, Mass,, July 1979.Levy, R. I., and Sondik, E. J., “Decision-Makingin Planning Large-Scale Comparative Studies, ”Ann. N. Y. Acad. Sci. 304:441, 1978.Levy, R. I., and Sondik, E. J., “The Managementof Biomedical Research: A Case in Point, ” in Bio-medical Innovation, E. B. Roberts, et al. (eds. )(Cambridge, Mass.: MIT Press, 1981).Levy, D., New York Hospital, personal commu-nication, April 1981.Levy, D., et al., “Prognosis in NontraumaticComa, ” Ann. Int. Med. 94(3):293, 1981.Light, R. J., and Smith, P. V., “AccumulatingEvidence: Procedures for Resolving Contradic-tions Among Research Studies, ” Harvard Educ.Rev. 41:429, 1976.Lohr, K. N., et al., Peer Review and TechnologyAssessment in Medicine, prepared for the Officeof Technology Assessment, U.S. Congress (SantaMonica, Calif.: Rand Corp., August 1981).Lowe, C. U., Office of Medical Applications ofResearch, National Institutes of Health, Bethesda,Md., personal communication, May 15, 1981.Lowe, C. U., “The Consensus Development Pro-gramme: Technology Assessment at the NationalInstitutes of Health, ” Ilr. Med. J. 28:1583, 1980.Luborsky, L., et al., “Comparative Studies ofPsychotherapies: Is It True That Everyone HasWon and All Must Have Prizes?” Arch. Gen.Psychiatry 32:995, 1975.Malkiel, B. G., “Productivity: The Problem Be-hind the Headlines, ” Harvard Bus. Rev. 57(3):81,1980.Malone, W. F., et al., “The Delphi Technique asan Instrument in Dental Curriculum Revision, ”L ~nt. Educ. 40:298, 1 9 7 6 .

233.

234.

235.

236.

237.

238.

239.

240.

241.

242,

243.

244.

245.

246.

247.

248.

Manning, P. R., and Denson, T. A., “How Car-diologists Learn About Echocardiography: A Re-minder for Medical Educators and Legislators, ”Ann. Int. Med. 91:469, 1979.Manning, P. R., and Denson, T. A., “How in-ternists Learned About Cimetidine, ” Ann. ht.Med. 92:690, 1980.Mansfield, E., et al., The Production and Appli-cation of New Industrial Technology (New York:Norton, 1977).Mather, H. G., et al., “Myocardial Infarction: AComparison Between Home and Hospital Carefor Patients, ” Br. Med. J. 1:925, 1976.McCleary, R., and Hay, R. A., Jr., Applied TimeSeries for the SociaZ Sciences (Beverl y Hills,Calif.: Sage Publications, 1980).McGinnis, W., Department of Defense, Tri-Serv-ice Medical Information Systems Program Office,Bethesda, Md., personal communication, Dec.10, 1981.McGuire, W. J., “The Nature of Attitudes andAttitude Change, “ in Handbook of Social Psy-chology, vol. 3., G. Lindzey and E. Aronson(eds.) (Reading, Mass.: Addison-Wesley, 1969).McNeer, J. F., et al., “The Nature of TreatmentSelection in Coronary Artery Disease: ExperienceWith Medical and Surgical Treatment of a Chron-ic Disease,” Circulation 49:606, 1974.McNeil, G. J., and Adelstein, S. J., “Determining

the Value of Diagnostic and Screening Tests, ” J.Nucl. Med. 17:439, 1976.Meier, P., University of Chicago, personal com-munication, Dec. 4, 1980.Meier, P., ‘The Biggest Public Health ExperimentEver: The 1954 Field Trial of the Salk PoliomyelitisVaccine, ” in Statistics: A Guide to the Unknown,J. M. Tanur, et al. (eds.) (San Francisco: Holden-Day, 1972).Merrill, R. A., “FDA Modes of Regulation andTheir Relationship to Private Sector Innovation,”prepared for the Office of Technology Assess-ment, U.S. Congress, Washington, D. C., 1980,Miao, L. L. “Gastric Freezing: An Example of theEvaluation of Medical Therapy by RandomizedClinical Trials,” in Costs, Risks, and Benefits ofSurgery, J. P. Bunker, et al. (eds. ) (New York:Oxford University Press, 1977).Milholland, A. V., et al., “Medical Assessmentby a Delphi Group Opinion Technique, ” N. Eng.J. Med. 288:1272, 1973,Miller, M. J., “FDA Voluntary Standards En-dorsement Policy: Victim of Legal Homicide, ”Med. Instrumentation 14:331, 1980.MitcheIl, A. A., et al., “Adverse Drug Effects and

98-144 0 - 82 - 15

Page 11: Strategies for Medical Technology Assessment (Part 20 of 21)

274 ● Strategies for Medical Technology Assessment

249.

250.

251.

252.

253.

254.

255.

256.

257.

258.

259.

260.

261.

262.

263.

264.

Drug Surveillance, ” in Pediatric F%arma-cology—Therapeutic Principles in Practice, S. J.Yaffe (cd.) (New York: Grune & Stratton, 1980).Moloney, T. W., and Rogers, D. E., “MedicalTechnology: A Different View of the ContentiousDebate Over Costs,” N. Eng. J A4ed. 301(26):1413, 1979.Moscovice, I., et al., “Health Services Researchfor Decision-Makers: The Use of the Delphi Tech-nique To Determine Health Priorities, ” -1. HealthPolit. Policy Law 3:388, 1977.Mosenkis, R., Emergency Care Research Insti-tute, Philadelphia, Pa., personal communication,August 1981.Mosteller, F., “Innovation and Evaluation, ” Sci-ence 211(4485):881, 1981.Muller, J. E., et al., “Let’s Not Let the GenieEscape From the Bottle—Again, ” N. Ehg. J. Med.304:1294, 1981.Murphy, M. L., et al., “Special Correspondence:A Debate on Coronary Bypass, ” N. Eng. J. Med.297:1470, 1977.Murphy, M. L., et al., “Treatment of ChronicStable Angina: A Preliminary Report of SurvivalData of the Randomized Veterans AdministrationCooperative Study,” N. Eng. J. Med. 297:621,1977.Myers, S., and Marquis, D. G., Successfid Indus-tria] Innovations, NSF 69-71 (Washington, D. C.:National Science Foundation, 1969).National Science Foundation, Science Indicators1978 (Washington, D. C.: NSF, 1978).Nelson, N. M., et al., “A Randomized ClinicalTrial of the Leboyer Approach to Childbirth,”N. Eng. J. Med. 302:655, 1980.Neustadt, R. D,, and Fineberg, H. V., The SwineFlu Affair: Decision-Making on a Slippery Dis-ease, GPO stock No. 017-000-002104 (Washing-ton, D. C.: U.S. Government Printing Office,1978).“New Device Introductions on the Rise,” IXv. &Diag. Letter 7:3, Aug. 12, 1980.Nine, H., Food and Drug Administration, Bureauof Medical Devices, Rockville, Md., personalcommunication, January 1981.Nisbett, R. E., and Ross, L. D., Human lhference:Strategies and Shortcomings of Social Ju~ment(Englewood Cliffs, N. J.: Prentice-Hall, 1980).Nobrega, F. T., et al., Mayo Clinic, Rochester,Minn., “Hospital Use in a Circumscribed Com-munity, ” unpublished paper, 1980.The Norwegian Multicenter Study Group,“Timolol-Induced Reduction in Mortality and Re-

265.

266.

267<

268.

269.

270.

271.

272.

273

274.

infarction in Patients Surviving Acute Myocar-dial Infarction,” N. Eng. J, Med. 304:801, 1981.Office of Technology Assessment, U.S. Congress,Annual Report to the Congress for 1977 (Wash-ington, D. C.: U.S. Government Printing Office,1978).Office of Technology Assessment, U.S. Congress,Assessing the Efficacy and Safety of MedicalTechnologies, GPO stock No. 052-003-00593-0(Washington, D. C.: U.S. Government PrintingOffice, September 1978).Office of Technology Assessment, U.S. Congress,Assessment of Technologies for fiterminingCancer Risks From the Environment, GPO stockNo. 052-003-00832-7 (Washington, D. C.: U.S.Goverment Printing Office, June 1981).Office of Technology Assessment, U.S. Congress,Computer Technology in Medical Education andAssessment, GPO stock No. 052-003-00704-5,(Washington, D. C.: U.S. Government PrintingOffice, September 1979).Office of Technology Assessment, U.S. Congress,fivelopment of Medical Technology: @portu-nities for Assessment, GPO stock No. 052-003-00217-5 (Washington, D. C.: U.S. GovernmentPrinting Office, August 1976).Office of Technology Assessment, U.S. Congress,The Implications of Cost-Effectiveness Analysisof Medical Technology, GPO stock No. 052-003-00765-7 (Washington, D. C.: U.S. GovernmentPrinting Office, August 1980).Office of Technology Assessment, U.S. Congress,The implications of Cost-Effectiveness Analysisof Medical Technology/Background Paper #l:Methodological Issues and Literature Review,GPO stock No. 052-003-00780-1 (Washington,D. C.: U.S. Government Printing Office, Septem-ber 1980).Office of Technology Assessment, U.S. Congress,The Implications of Cost-Effectiveness Analysisof Medical Technology/Background Paper #2:Case Studies of Medical Technologies (Washing-ton, D. C.: U.S. Government Printing Office,1981).Office of Technology Assessment, U.S. Congress,The Implications of Cost-Effectiveness Analysisof Medical Technology/Background Paper #3:The Efficacy and Cost Effectiveness of Psycho-therapy, GPO stock No, 052-003-00780-5 (Wash-ington, D. C.: U.S. Government Printing Office,October 1980).Office of Technology Assessment, U.S. Congress,The Implications of Cost-Effectiveness Analvsis.

Page 12: Strategies for Medical Technology Assessment (Part 20 of 21)

References “ 215—-—— — - — — — —— . — - — . — . — — — — — — — — . . — — - . — — —

275.

276.

277.

278.

279,

280.

281.

282,

283.

284,

285,

286,

287,

of Medical Technology/Background Paper #4:The Management of Health Care Technology inTen Countries, GPO stock No. 052-003-00780-3(Washington, D. C.: [J.S. Government PrintingOffice, October 1980).Office of Technology Assessment, U.S. Congress,Medical Technology Under Proposals To IncreaseCompetition in Heahh Care, in press, 1982.Office of Technology Assessment U.S. Congress,MEDLARS and Health Information Policy, inpress, 1982.Office of Technology Assessment, U.S. Congress,“The National Center for Health Care Technol-ogy and Medical Technology Assessment Policy, ”staff paper, Mar. 16, 1981.Office of Technology Assessment, U.S. Congress,“The National Library of Medicine, ” staff paper,Mar. 17, 1981.Office of Technology Assessment, U.S. Congress,Policy Implications of the Computed Tomogra-phy (CT) Scanner, GPO stock No. 052-003-00565-4, (Washington, D. C.: U.S. GovernmentPrinting Office, August 1978).Office of Technology Assessment, U.S. Congress,Policy Implications of the Computed Tomogra-phy (CT) Scanner: An Update, GPO stock No.052-003-00793-2, (Washington, D. C.: U.S. Gov-ernment Printing Office, January 1981).Office of Technology Assessent, U.S. Congress,Postmarketing Surveillance of PrescriptionDrugs, in press, 1982.Office of Technology Assessment, U.S. Congress,Selected Topics in Federal Health Statistics, GPOstock No. 052-003 -00683-9 (Washington, D. C.:U.S. Government Printing Office, June 1979).Office of Technology Assessment, U.S. Congress,Technological Innovation and Health, Safety,and Environmental Regulations, in press, 1982.Okie, S., “Hard To Put Price on Heart Surgery’sValue,” The Washington Post, Apr. 27, 1981,A13.Palmour, R. M., and Ervin, F. R., “Biochemicaland Behavioral Studies of a Peptide Derived Fromthe Dialysate of Psychiatric Patients, ” presentedat the 24th Annual Meeting of the American Soci-ety for Artificial Internal Organs, April 1978.Patton, M. Q., Qualitative Evaluation Methods(Beverly Hills, Calif.: Sage Publications, 1979).Perry, S., and Kalberer, J. T., Jr., “The NIH Con-sensus-Development Program and the Assess-ment of Health Technologies: The First TwoYears,” N. Eng. J. Med. 303:169, 1980.

288.

289.

290.

291.

292

293,

294.

295.

296.

297.

298.

299.

300.

301.

302.

Peterson, R. D., and MacPhee, C. R., EconomicOrganization in Medical Equipment and Supply(Lexington, Mass.: D. C. Heath & Co., 1973).Pete, R., et al., “Design and Analysis of Random-ized Clinical Trials Requiring Prolonged Obser-vation of Each Patient: 1. Introduction and De-sign,” Br. J. Cancer 34:585, 1976.Pickup, J. C., and Keen, H., “Continuous Sub-cutaneous Insulin Infusion: A Developing Toolin Diabetes Research, ” Diabetologia 18:1, 1980.Pickup, J. C., et al., “Continuous SubcutaneousInsulin Infusion: Improved Blood-Glucose and In-termediary-Metabolite Control in Diabetics, ”Lancet 1:1255, 1979.Pillemer, D. B., and Light, R. J., “synthesizingOutcomes: How To Use Research Evidence FromMany Studies, ” Harvard Educ. Rev. 50:176,1980.Policy Research, Inc., Baltimore, Md., MedicalPractice Information Demonstration Project,final report to the Office of the Assistant Secre-tary for Health, Department of Health, Educa-tion, and WeIfare, contract No. 282-77-0068 GS,December 1979.Posavac, E. J., “Evaluations of Patient EducationPrograms: A Meta-Analysis, ” Eva]. Health Pro-fess. 3:47, 1980.Powledge, T. M., and Fletcher, J., “Guidelinesfor the Ethical, Social and Legal Issues in PrenatalDiagnosis,” N. Eng. J. Med. 300:168, 1979.President’s Commission for the Study of EthicalProblems in Medicine and Biomedical and Behav-ioral Research, Dfining Death: Medical, Legaland Ethical Issues in the Determination of Bath(Washington, D. C.: U.S. Government PrintingOffice, July 1981).Preston, T. A., Coronary Artery Surgery: A Crit-ical Review (New York: Raven, 1977),Quinn, J. G., “Why Executives Think Short, ”Newsweek, July 13, 1981.Radzius, J. R., “FDA Regulation of Drugs,Devices, ” AORN J. 24:254, 1976.Ramroth, D. N. (cd.), Proceedings From theMedical and Scientific Section Meeting on Get-ting New Products to the Market (Washington,D. C.: Health Industry Manufacturers Associa-tion, 1979).Rapoport, J., “Diffusion of Technological inno-vation Among Non-Profit Firms: A Case Study

of Radioisotopes in U.S. Hospitals, ” J, Econ. BUS.301:108, 1 9 7 8 .Registry for Research on Hormonal Transplacen-

Page 13: Strategies for Medical Technology Assessment (Part 20 of 21)

216 Strategies for Medical Technology Assessment

303.

304.

305.

306.

307.

308.

309.

310.

311.

312.

313.

314.

315.

316.

317.

318.

tal Carcinogenesis, 1978 Newsletter, Chicago,n.d.Registry for Research on Hormonal Transplacen-tal Carcinogenesis, 1979-80 Newsletter, Chicago,n.d.Reich, W. T. (cd.), Encyclopedia of Bioethics(New York: Free Press, 1978).Reiss, J. B., “Issues in the Cost and Regulationof New Medical Technologies and Procedures:Heart Transplants as a Case Study,” presentedto the Harvard-MIT Conference on MedicalTechnology, Boston, Apr. 13-16, 1980.Reiss, J. B., “Technology Assessment and Pay-ing for Medical Services Provided Patients, ” pre-pared for the Office of Technology Assessment,U.S. Congress, Washington, D. C., April 1981.Relman, A. S., “Assessment of Medical Prac-tices,” IV. Eng. J. Med. 303(3):153, 1980.Rennie, R. A., “Consensus Statements, ” N. Ehg.J Med. 303:153, 1980.Research News, The Diabetes Research andTraining Center: New Assault on an Old Enemy(Ann Arbor: University of Michigan, May,1979).Rettig, R. A., “The Federal Government andMedical Technology: Crossing Policy and Man-agement Thresholds, ” PoZicy Sci. 11:343, 1980.Riecken, H. W., and Boruch, R. F. (eds. ), Socialfiperimentation: A Method for Planning andEvacuating Social Intervention (New York:Academic Press, 1975).Rindskopf, D., “Using Structural Equation Mod-els To Analyze Nonexperimental Data, ” in Re-analyzing Program Evaluations: Policies andPractices for Secondary halysis of SociaZ andEducational Programs, R. F. Boruch, et al. (eds. )(San Francisco: Jossey-Bass, in press).Roberts, E. B., “Influences on Innovation: Extrap-olations to Biomedical Technology, ” in Biomedi-cal Innovation, E. B. Roberts, et al. (eds. ) (Cam-bridge, Mass.: MIT Press, 1981).Robinson, J. A., “Coronary Care Unit VersusHospital Mortality in Acute Myocardial Infarc-tion,” Israel J. Med. Sci. 5:772, 1969.Rodak, J., National Center for Health Care Tech-nology, Rockville, Md., personal communica-tion, December 1980.Roe, B. B., “The UCR Boondoggle: A DeathKnell for Private Practice?” N. Eng. J. Med.305(1):41, 1981.Rogers, E. M., and Shoemaker, F. F., Communi-cation of Innovations: A Cross-Cultural Ap-proach, 2d ed. (New York: Free Press, 1971).Romm, F. J., and Hulka, B. S., “Developing Cri-teria for Quality of Care Assessment: Effect of

319.

320.

321.

322.

323.

324.

325.

326.

327.

328.

329<

330.

331,

332s

333.

334.

335.

336,

337.

the Delphi Technique, “ HeaZth Serv. Res. 14:309,1979.Roos, L. L., Jr., et al., “Assessing the Impact ofTonsillectomies, ” Med. Care 16(6):502, 1978.Roos, L. L., Jr., et al., “Using AdministrativeData Banks for Research and Evaluation: A CaseStudy,” EvaJuat. Q. 3(2):236, 1979,Roosf N. P., “Who Should Do the Surgery? Ton-sillectomy-Adenoidectomy in One CanadianProvince,” Inquiry 16(1):73, 1979.Roos, N. P., et al., “A New Audit Procedure Ap-plied to an Old Question: Is the Frequency ofT&A Justified?” Med. Care 15(1):1, 1977.Rosati, R., et al., Expansion, Ektension, and EvaLuation of a C~nical Databank for Coronary Ar-tery Disease, contract No. HRA 230-76-0300,submitted to the National Center for Health Serv-ices Research, Hyattsville, Md., August 1980.Rosenthal, R., “Combining Results of Independ-ent Studies,” Psychol. Bull. 85:185, 1978.Rosenthal, R., fiperimenter Effects in BehavioralResearch (New York: Irvington, 1976).Ross, R. S., “Ischemic Heart Disease: An Over-view,” Am. J. Cardiol. 38:496, 1975.Rothwell, R., and Zegveld W., “The Role ofSmall Manufacturing Enterprises in Innovation, ”P. Innov. 2(1):3, 1979.Rubenstein, L., et al., “Quality of Care Assess-ment by Process and Outcome Scoring, ” Ann. Ln-tern. Med. 86:617, 1977.Ruffin, J. M., et al., “A Co-Operative Double-Blind Evaluation of Gastric Freezing in the Treat-ment of Duodenal Ulcer, ” N. Ehg. J. Med. 281:16,1969.Runyon, R. P., and Haber, A., Fundamentals ofBehaviora~ Statistics, 3d ed. (Reading, Mass.:Addison-Wesley, 1976).Russell, L. B., Technology in Hospitals: MedicalAdvances and Their Diffusion (Washington,D. C.: The Brookings Institution, 1979).Ryder, H. W., letter to the editor, N. Ehg. J. Med.296:45, 1977.Salkever, D., and Bice, T., Hospital Certificate-of-Need Controls: Impact on Investment, Costs,and Use (Washington, D. C.: American EnterpriseInstitute for Public Policy Research, 1979).Salkever, D., and Bice, T., “The Impact ofCertificate-of-Need Controls on Hospital Invest-ment,” Milbank Mere. Fund Q. 54:185, 1976.Saxe, L., and Fine, M., Social Experiments:Methods for Design and Evaluation (BeverlyHills, Calif.: Sage Publications, 1981).Schoenbaum, S. C., et al., “The Swine-InfluenzaDecision, ” N. Eng. J. Med. 295:759, 1976.Schor, S., and Karten, I., “Statistical Evaluation

Page 14: Strategies for Medical Technology Assessment (Part 20 of 21)

References ● 217

338.

339.

340.

341.

342.

343.

344.

345.

346.

347.

348.

349<

350.

351.

352.

of Medical Journal Manuscripts, ” ~. A. M A.195:145, 1966.Schulz, S. C., et al., “Dialysis in Schizophrenia:A Double-Blind Evaluation, ” Science 211:1066,1981.Scriven, M., “The Methodology of Evaluation, ”in Perspectives of Curriculum Evaluation, R. W.Tyler, et al. (eds. ) (Chicago: Rand McNally,1967).Sechrest, L., et al,, “Introduction-Some Ne-glected Problems in Evaluation Research:Strength and Integrity of Treatments” in Evalua-tion Studies Review Annual, vol. 4, L. Sechrest,et a]. (eds. ) (Beverly Hills, Calif.: Sage Publica-tions, 1979).Shapiro, S., “Evidence on Screening for BreastCancer From a Randomized Trial, ” cancer39:2772, 1977.Sherman, M. A., “Mobile Intensive Care Units:An Evaluation of Effectiveness, ” J, A.M.A.241:1899, 1979.Sherman, M. A., et al., “Threats to the Validityof Emergency Medical Services Evaluation, ”Med. Care 17:127, 1979.Shields, S., Hospital Utilization Plan, Pittsburgh,Pa., personal communication, May 8, 1981.Shrader-Frechette, A., “Technology Assessmentas Applied Philosophy of Science, ” Sci. TechnoZ.Human Values 6:33, 1980.Silverman, W. A., “The Lesson of RetrolentalFibroplasia, ” Sci. Am. 236(6):100, 1977.Silvers, J. B., “Competitive Economics of HealthCare Providers in the 1980’s: The Case of theLarge National Clinics, ” presented at the ProjectHOPE conference, “The Role of Major MedicalClinics in Meeting Future National HealthNeeds,” Millwood, Va., Mar. 11-13, 1981.Singer, D., et al., “Unexpected Readmission tothe Coronary Care Unit During Recovery FromAcute Myocardial Infarction, ” N. Eng. J Med.,304(11):625, 1981.Singer, I. D., Washington, D. C., “Notes onFederal Efforts in Ethics and Health Policy, ” per-sonal communication, 1981.Siperstein, M. D., et al., “Control of BloodGlucose and Diabetic Vascular Disease, ” N. Eng.J Med. 296:1060, 1977.Skolnick, M., “The Utah Genealogical Data Base:A Resource for Genetic Epidemiology, ” in Ban-bury Report 4: Cancer Incidence in LHinedPop-ulations (Cold Spring Harbor, N. Y.: Cold SpringHarbor Laboratory, 1980).Skolnick, M., et al., “A Computerized FamilyHistory Data Base System, ” Sociol. & Soc. Res.,63(3):507, 1979.

353,

354,

355

356,

357,

358,

359.

360.

361.

362.

363.

364.

365.

366.

367,

368.

369,

Smith, M. L,, and Glass, G. V., “Meta-Analysisof Psychotherapy Outcome Studies, ” Am.psycho]. 32:752, 1977.Smith, M. L., et al., The Benefits of Psychother-apy (Baltimore: Johns Hopkins University Press,1981).Smithson, L., Structure of the U.S. MedicalSupply, Z@ipment, andlkices Industries (Stan-ford, Calif.: SRI International, 1979).Sonnenfeld, J. A., “The Blue Cross and BlueShield Associations’ Medical Necessity Program, ”VoZunt. Effort Q. 3(2):5, 1981.Speer, D. C., and Tapp, J. C., “Evaluation ofMental Heahh Service Effectiveness: A “Start Up”Model for Established Programs, ” Am. ). Ortho-psych. 46:217, 1976.Spodick, D. H., “The Surgical Mystique and theDouble Standard: Controlled Trials of Medicaland Surgical Therapy for Cardiac Disease, ” Am.Heart J 85:579, 1973.Stein, D. J., “Manufacturers of Medical DevicesJoin the Chorus of Regulatory Critics, ” NationalJ 12(38):1556, 1 9 8 0 .Stinson, E. R., and Mueller, D. A., “Survey ofHealth Professionals’ Information Habits andNeeds: Conducted Through Personal Interviews, ”J. A.M.A. 243(2):140, 1980.Tamborlane, W. V., et al., “Restoration of Nor-mal Lipid and Amino Acid Metabolism in Dia-betic Patients Treated With a Portable Insulin-Infusion Pump, ” Lancet 1:1258, 1979.Tattersall, R. B., “Home Blood Glucose Monitor-ing,” DiabetoZogia 16:71, 1979.Temple, R., and Pledger, G. W., “The FDA’sCritique of the Anturane Reinfarction Trial, ” N.Eng. J Med. 303:1488, 1980.Thacker, S., Center for Disease Control, Atlan-ta, Ga., personal communication, April 1981.Thibault, G. E., et al., “Medical Intensive Care:Indications, Interventions, and Outcomes,” N.Ertg. J Med., 302(17):938, 1980.Thomas, L., Lives of a CeZl (New York: BantonBooks, Inc., 1975).Thompson, M. S., and Cohen, A. B., “DecisionAnalysis: Electronic Fetal Monitoring,” in A4eth-ods of Evaluating Health Services, P. M. Wort-man (cd. ) (Beverly Hills, Calif.: Sage Publica-tions, 1981).Thornell, C. A., Comparison of Strategies for theDevelopment of Process Measures in EmergencyMedical Services, NCHSR Research SummarySeries (Hyattsville, Md.: National Center forHealth Services Research, 1981).Tilson, D., et al., “The Federal Interest, ” in TheDiffusion of Medical Technology, G. Gordon and

Page 15: Strategies for Medical Technology Assessment (Part 20 of 21)

218 ● Strategies for Medical Technology Assessment

370<

371.

372.

373.

374.

375.

376.

377.

378.

379.

380.

381.

382.

383.

384.

385

386

G. L. Fisher (eds. ) (Cambridge, Mass.: Ballinger,1975).Toffler, A., The Third Wave (New York: WilliamMorrow & Co., 1980).Tosteson, D. C., “Lithium and Mania, ” %i. Am.244:164, 1981.Towery, O. B., and Perry, S., “The ScientificBasis for Coverage Decisions by Third-Party Pay-ers, J. A.M.A. 245(1):59, 1981.Tribe, H., “Technology Assessment and theFourth Discontinuity: The Limits of Instrumen-tal Rationality, ” S. CaZil Law Rev. 46:617, 1973.Tversky, A., and Kahneman, D., “JudgmentUnder Uncertainty: Heuristics and Biases,”science 185:620, 1974.Utterback, J. M., “Innovation in Industry and theDiffusion of Technology,” Science 183:620, 1974.Utterback, J. M., and Abernathy, W. J., “A Dy-namic Model of Process and Product Innova-tion, ” bega 3(6):639, 1975.Veatch, R. M., Bethesda, Md., “Consensus De-velopment in Medical Technology: Problems forPlanning a Consensus Conference on CoronaryArtery Bypass Surgery, ” unpublished, 1980.Veatch, R. M., and Branson, R. (eds.), Ethics andHealth Policy (Cambridge, Mass.: Ballinger,1976).Wagemaker, H., Jr., and Cade, R., “The Use ofHemodialysis in Chronic Schizophrenia, ” Am. J.Psychiatry 134:684, 1977.Wagner, J. L., “Toward a Research Agenda onMedical Technology,” in Medical Technology,publication No. (PHS) 19-3254 (Washington,D. C.: U.S. Government Printing Office, 1979).Wangensteen, O. H., et al., “Achieving ‘Physio-logical Gastrectomy’ by Gastric Freezing, ”J, A.M.A. 180:95, 1962.Warner, K. E., “A ‘Desperation-Reaction’ Modelof Medical Diffusion, ” Health Serv. Res. 10:369,1975.Warner, K. E., and Luce, B. R., Cost-Benefit andCost-Effectiveness Analysis in Health Care: Prin-ciples, Practice, and Potential (Ann Arbor,Mich.: Health Administration Press, Universityof Michigan, in press).Warren, K. S., (cd.), Coping With BiomedicalLiterature (New York: Praeger, 1981).Watkins, R,, Group Health Cooperative, Seat-tle, Wash., personal communication, May 6,1981.Weinstein, M. C., and Fineberg, H. V., ClinicalDecision Analysis (Philadelphia: W. B. Saunders,1980).

387.

388.

389

390!

391.

392.

393.

394.

395.

396.

397,

398.

399.

400.

401.

402.

Weiss, D. H., Evacuation Research: Methods forAssessing Program Effectiveness (EnglewoodCliffs, N. J.: Prentice-Hall, 1972).Wennberg, J. E., “Commentary: Physician Un-certainty, Specialty, Idealogy, and a SecondOpinion to Tonsillectomy,” Pediatrics 59:952,1977.Wennberg, J. E., et al., “The Need for Assessingthe Outcome of Common Medical Practices, ”Ann. Rev. Public Health 1:277, 1980.Wennberg, J. E., et al., “Some Uses of ClaimsData for the Analysis of Surgical Practicesf ” inProceedings of the 18th National Public HealthConference on Records and Statistics, DHHSpublication No. (PHS) 81-1214, August 1980.Whittaker, G. F., “The Evaluation of a MergedHospital System: Application of the InterruptedTime-Series Design,” Evaluat. Rev. 5:68, 1981.Willems, J., “The Relationship Between the Dif-fusion of Medical Technology and the Organiza-tion and Economics of Health Care Delivery, inMedicaZ Technology, J. Wagner (cd.), DHEWpublication No. (PHS) 79-3254, 1979.Williams, M. E., University of Illinois, Cham-paign-Urbana, 111., personal communication,March 1981.Williams, M. E., et al. (cd.), Computer ReadableData Bases: A Compendium and Source Book(Washington, D. C.: American Society for Infor-mation Science, 1979).Williams, M. E., “Database and Online Statisticsfor 1979,” ASIS Bulletin 7(2):27, 1980.Williamson, J. W., Johns Hopkins University,“Reformation of Project Goals, ” unpublishedpaper, 1981.Wolf, C., Jr., Ethics and Policy Analysis (SantaMonica, Calif.: Rand Corp., February 1980).Wolf, S., “High Time for Synthesis, ” Forum onMedicine 3:502, 1980.Worthen, D. B., “Prescribing Influences: AnOverview,” Br. J. Med. Educ. 7:109, 1973.Wortman, P. M., “Consensus Development, ” inMethods for Evaluating Health Services, P. M.Wortman (cd.) (Beverly Hills, Calif.: Sage Pub-lications, 1981).Wortman, P. M., “Randomized Clinical Trials, ”in Method for Evaluating Health Services, P. M.Wortman (cd. ) (Beverly Hills, Calif.: Sage Pub-lications , 1981).Wortman, P. M., et al., “The First Year of theEducation Voucher Demonstration: A SecondaryAnalysis of Student Achievement Test Scores, ”Eval. Q. 2:193, 1978.

Page 16: Strategies for Medical Technology Assessment (Part 20 of 21)

403.

404.

405.

Wylie, J. H., et al., “Effect of Cimetidine on Sur- 406.gery for Duodenal Ulcer, ” Lancet 1:1307, 1981.Young, D. A., “Communications Linking ClinicalResearch and Clinical Practice, ” in Biornedica~ ~- 407.novation, E. B. Roberts, et al. (eds. ) (Cambridge,Mass.: MIT Press, 1981).Zaltman, G., et al., Innovations and Organiza-tions (New York: John Wiley & Sons, 1973).

References . 219-- ——.— — .——

Zimmerman, H., Rhode Island Health ServicesResearch, Inc., Providence, R. I., personal com-munication, Apr. 17, 1981.Zwick, D., Bethesda, Md., personal communica-tion, December 1981.